Cardlytics

Q2 FY2026 EarningsQ2 FY26 results were mixed relative to consensus: revenue of $36.9M slightly missed the $37.0M mean estimate, while Adjusted Net Loss of $(0.81) was significantly better than the $(1.35) expected. Despite a 36% YoY revenue decline following the Bridg divestiture, Adjusted EBITDA beat at $1.7M. However, Free Cash Flow of $(10.7)M was worse than the $(8.7)M floor expected by analysts, and Q3 FY26 revenue guidance of $34M-$39M suggests continued top-line pressure compared to historical levels.